Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA307867
Max Phase: Preclinical
Molecular Formula: C9H11N3O2
Molecular Weight: 193.21
Molecule Type: Small molecule
Associated Items:
ID: ALA307867
Max Phase: Preclinical
Molecular Formula: C9H11N3O2
Molecular Weight: 193.21
Molecule Type: Small molecule
Associated Items:
Synonyms (2): 4-Methoxybenzaldehyde Semicarbazone | P-Methoxy-Phenylsemicarbazone
Synonyms from Alternative Forms(2):
Canonical SMILES: COc1ccc(/C=N/NC(N)=O)cc1
Standard InChI: InChI=1S/C9H11N3O2/c1-14-8-4-2-7(3-5-8)6-11-12-9(10)13/h2-6H,1H3,(H3,10,12,13)/b11-6+
Standard InChI Key: OGMVRNVTFDFHHE-IZZDOVSWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 193.21 | Molecular Weight (Monoisotopic): 193.0851 | AlogP: 0.70 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.87 | CX Basic pKa: 1.68 | CX LogP: 0.62 | CX LogD: 0.62 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.55 | Np Likeness Score: -1.57 |
1. Dimmock JR, Sidhu KK, Thayer RS, Mack P, Duffy MJ, Reid RS, Quail JW, Pugazhenthi U, Ong A, Bikker JA.. (1993) Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indices., 36 (16): [PMID:8360870] [10.1021/jm00068a001] |
2. de Oliveira RB, de Souza-Fagundes EM, Soares RP, Andrade AA, Krettli AU, Zani CL.. (2008) Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives., 43 (9): [PMID:18222568] [10.1016/j.ejmech.2007.11.012] |
3. Ferreira FB, Pereira TM, Souza DLN, Lopes DS, Freitas V, Ávila VMR, Kümmerle AE, Sant'Anna CMR.. (2017) Structure-Based Discovery of Thiosemicarbazone Metalloproteinase Inhibitors for Hemorrhage Treatment in Snakebites., 8 (11): [PMID:29152044] [10.1021/acsmedchemlett.7b00186] |
Source(1):